Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MDC-75
- Development stage
- Unknown
- Lead developer
- R & D Pharma
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
MDC-75 is a proprietary topical solution containing a high concentration (75%) of hydrogen peroxide, developed by R&D Pharma for the non-invasive removal of various benign superficial skin lesions. It is primarily indicated for the treatment of seborrheic keratosis, common warts (verruca vulgaris), benign dermal naevi, skin tags, and isolated low-grade actinic keratosis. The mechanism of action involves the induction of localized oxidative stress and chemical cauterization upon application to the lesion. This process leads to protein denaturation, lipid peroxidation, and subsequent tissue necrosis, causing the abnormal growth to slough off over time. MDC-75 is typically administered by a healthcare professional in a clinical setting and has been evaluated in clinical performance studies in Mauritius.
- Brand names
- MDC-75MDC75MDC 75
- Other names
- hydrogen peroxide 75% solution
Beyond the preview
Go deeper on MDC-75.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MDC-75.